A study of blood sugar reducing effect of homoeopathic medicine Pterocarpus marsupium under laboratory setting with clinical evaluation of the same in Type 2 Diabetes Mellitus

IN VITRO EVALUATION OF ANTIDIABETIC ACTIVITY OF HOMOEOPATHIC MEDICINE PTEROCARPUS MARSUPIUM AND A RANDOMIZED CONTROLLED CLINICAL TRIAL IN TYPE 2 DIABETIC PATIENTS - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075883

Enrollment

Registered

2024-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Pterocarpus Marsupium: Pterocarpus Marsupium 1M one drop in sugar of milk as one dose monthly once orally for a total duration of 3 month Control Intervention1: homoeopathic constitutio

Eligibility

Inclusion criteria

Inclusion criteria: fasting blood glucose greater than 126mg/dl type 2 diabetic patients of age group between 30-70 years of both sexes

Exclusion criteria

Exclusion criteria: cases with severe illness,malignancy chronic alcoholic persons and chronic smokers type 2 diabetic patients with fasting blood glucose greater than 300 mg/dl

Design outcomes

Secondary

Measure	Time frame
comparison of therapeutic effectiveness of pterocarpus marsupium and homoeopathic constitutional medicine among the groupTimepoint: after 1 year	—

Primary

Measure	Time frame
title-reduction in the fasting blood glucose concentration description-glucose baseline value-final concentration of glucoseTimepoint: FBG will be accessed after 4 weeks, 8 weeks and 12 weeks of treatment.	—

Countries

India

Contacts

Public ContactDr Sreya V S

govt homoeopathic medical college kozhikode

drmansoorkr@gmail.com9249337799

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026